• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

用于脑膜炎球菌病的外膜蛋白囊泡疫苗。

Outer membrane protein vesicle vaccines for meningococcal disease.

作者信息

Frasch C E, van Alphen L, Holst J, Poolman J T, Rosenqvist E

机构信息

Division of Bacterial Products, Center for Biologics Evaluation and Research, Rockville, MD.

出版信息

Methods Mol Med. 2001;66:81-107. doi: 10.1385/1-59259-148-5:81.

DOI:10.1385/1-59259-148-5:81
PMID:21336749
Abstract

Alternative strategies exist for prevention of group B Neisseria meningitidis (meningococcal) disease through vaccination (see Chapters 5 , 8 , 13 , 14 in this volume). However, the most promising approach to date has been the use of outer-membrane vesicle (OMV) vaccines for induction of bactericidal antibodies against cell-surface outer-membrane proteins (OMPs).

摘要

通过接种疫苗预防B群脑膜炎奈瑟菌（脑膜炎球菌）病存在其他策略（见本卷第5、8、13、14章）。然而，迄今为止最有前景的方法是使用外膜囊泡（OMV）疫苗来诱导针对细胞表面外膜蛋白（OMP）的杀菌抗体。

相似文献

1
Outer membrane protein vesicle vaccines for meningococcal disease.用于脑膜炎球菌病的外膜蛋白囊泡疫苗。
Methods Mol Med. 2001;66:81-107. doi: 10.1385/1-59259-148-5:81.
2
Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease.一种针对A群脑膜炎奈瑟菌病的外膜蛋白囊泡疫苗在小鼠体内的免疫原性和杀菌活性。
Vaccine. 2004 Jun 2;22(17-18):2171-80. doi: 10.1016/j.vaccine.2003.11.047.
3
Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.抗A群脑膜炎奈瑟菌外膜囊泡疫苗的研发与特性分析
Vaccine. 2005 May 31;23(29):3762-74. doi: 10.1016/j.vaccine.2005.02.021. Epub 2005 Mar 14.
4
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.含有脑膜炎奈瑟菌外膜囊泡的疫苗的特性及临床性能
Vaccine. 2009 Jun 24;27 Suppl 2:B3-12. doi: 10.1016/j.vaccine.2009.04.071. Epub 2009 May 28.
5
Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice.佐剂可以增强OMV疫苗对新生小鼠B/C群脑膜炎奈瑟菌的免疫保护作用。
FEMS Immunol Med Microbiol. 2004 Jul 1;41(3):205-10. doi: 10.1016/j.femsim.2004.03.005.
6
Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254.对由B群菌株NZ98/254制备的脑膜炎球菌外膜囊泡疫苗进行蛋白质组学分析。
Proteomics. 2006 Jun;6(11):3400-13. doi: 10.1002/pmic.200500821.
7
Outer membrane proteins of Neisseria meningitidis: structure and importance in meningococcal disease.
Clin Invest Med. 1986;9(2):101-7.
8
Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines.脑膜炎奈瑟菌外膜囊泡的佐剂特性及佐剂在脑膜炎奈瑟菌蛋白疫苗中的应用。
Expert Rev Vaccines. 2011 Mar;10(3):323-34. doi: 10.1586/erv.11.10.
9
Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants.基于无毒脂多糖突变体的新一代抗脑膜炎奈瑟菌外膜囊泡疫苗。
Hum Vaccin. 2011 Aug;7(8):886-90. doi: 10.4161/hv.7.8.16086. Epub 2011 Aug 1.
10
New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months.新西兰流行株B群脑膜炎球菌外膜囊泡疫苗用于16至24月龄儿童
Pediatr Infect Dis J. 2007 Apr;26(4):345-50. doi: 10.1097/01.inf.0000258697.05341.2c.

引用本文的文献

1
Optimization of methods for isolation and purification of outer membrane vesicles (OMVs) from Neisseria lactamica.从乳酸奈瑟菌中分离和纯化外膜囊泡（OMV）方法的优化。
Appl Microbiol Biotechnol. 2025 Apr 7;109(1):82. doi: 10.1007/s00253-025-13460-y.
2
Targeted siRNA Delivery by Bioinspired Cancer Cell Membrane-Coated Nanoparticles with Enhanced Anti-Cancer Immunity.仿生癌细胞膜包覆纳米粒子靶向递送来增强抗癌免疫。
Int J Nanomedicine. 2023 Oct 24;18:5961-5982. doi: 10.2147/IJN.S429036. eCollection 2023.
3
Outer membrane vesicles as versatile tools for therapeutic approaches.
外膜囊泡作为治疗方法的通用工具。
Microlife. 2021 Jun 8;2:uqab006. doi: 10.1093/femsml/uqab006. eCollection 2021.
4
Product review on the IMD serogroup B vaccine Bexsero®.关于 IMD 血清群 B 疫苗 Bexsero®的产品评价。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2020043. doi: 10.1080/21645515.2021.2020043. Epub 2022 Feb 22.
5
Robust Immune Response Induced by TSP-2 Antigen Coupled to Bacterial Outer Membrane Vesicles.TSP-2 抗原偶联细菌外膜囊泡诱导的强大免疫应答。
Int J Nanomedicine. 2021 Oct 22;16:7153-7168. doi: 10.2147/IJN.S315786. eCollection 2021.
6
Primary and Memory Response of Human Monocytes to Vaccines: Role of Nanoparticulate Antigens in Inducing Innate Memory.人类单核细胞对疫苗的初次和记忆反应：纳米颗粒抗原在诱导固有记忆中的作用
Nanomaterials (Basel). 2021 Apr 6;11(4):931. doi: 10.3390/nano11040931.
7
Stability of Outer Membrane Vesicles-Based Vaccines, Identifying the Most Appropriate Methods to Detect Changes in Vaccine Potency.基于外膜囊泡的疫苗的稳定性，确定检测疫苗效力变化的最合适方法。
Vaccines (Basel). 2021 Mar 6;9(3):229. doi: 10.3390/vaccines9030229.
8
Outer membrane vesicles: moving within the intricate labyrinth of assays that can predict risks of reactogenicity in humans.外膜囊泡：在错综复杂的人类反应原性风险预测检测实验中游走。
Hum Vaccin Immunother. 2021 Feb 1;17(2):601-613. doi: 10.1080/21645515.2020.1780092. Epub 2020 Jul 20.
9
A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.一种脑膜炎球菌外膜囊泡疫苗，过表达突变 FHbp，在婴儿恒河猴中引起的保护性抗体反应高于已许可的 B 型脑膜炎球菌疫苗。
mBio. 2019 Jun 18;10(3):e01231-19. doi: 10.1128/mBio.01231-19.
10
The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology.利用反向疫苗学开发 B 型脑膜炎球菌疫苗。
Front Immunol. 2019 Apr 16;10:751. doi: 10.3389/fimmu.2019.00751. eCollection 2019.